EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses

Jorge Nuche, Amr E Abbas, Vicenç Serra, Victoria Vilalta, Luis Nombela-Franco, Ander Regueiro, Karim M Al-Azizi, Ayman Iskander, Lenard Conradi, Jessica Forcillo, Scott Lilly, Alvaro Calabuig und 6 weitere

JACC: Cardiovascular Interventions · 2023-12 · 16 (24) · 2999-3012

DOI: 10.1016/j.jcin.2023.10.028 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2023-12. Verfasst von Jorge Nuche und 17 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Bioprosthesis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Data comparing valve systems in the valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) field have been obtained from retrospective studies. OBJECTIVES: The authors sought to compare the 1-year hemodynamic performance and clinical outcomes between balloon-expandable valves (BEV) SAPIEN 3/ULTRA (Edwards Lifesciences) and self-expanding valves (SEV) Evolut R/PRO/PRO+ (Medtronic) in ViV-TAVR. METHODS: Patients with a failed small (≤23 mm) surgical valve undergoing ViV-TAVR were randomized to receive a SEV or a BEV. Patients had a clinical and valve hemodynamic (Doppler echocardiography) evaluation at 1-year follow-up. Study outcomes were defined according to VARC-2/VARC-3 criteria. Intended performance of the valve was defined as mean gradient II, BEV: 7.3%, SEV: 4.1%; P = 0.505) or quality of life (Kansas City Cardiomyopathy Questionnaire, BEV: 77.9 ± 21.2, SEV: 81.8 ± 14.8; P = 0.334). No differences in all-cause mortality (BEV: 6.5%, SEV: 3.8; P = 0.495), heart failure hospitalization (BEV: 6.5%, SEV: 1.9%; P = 0.214), stroke (BEV: 0%, SEV: 1.9%; P = 0.369), myocardial infarction (BEV: 0%, SEV: 1.9%; P = 0.347), or pacemaker implantation (BEV: 2.2%, SEV: 1.9%; P = 0.898) were found. CONCLUSIONS: In patients who underwent ViV-TAVR for failed small aortic bioprostheses, those receiving a SEV exhibited a better valve hemodynamic profile at 1-year follow-up. There were no differences between SEV and BEV regarding functional status, quality of life, or clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisBioprosthesisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementHumansAortic ValveRetrospective StudiesQuality of LifeTreatment OutcomeProsthesis Design

Stichwörter der Autor:innen

TAVRfailed bioprosthesisvalve-in-valve

Autor:innen und Institutionen

  • Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Corewell Health East, William Beaumont University Hospital, Royal Oak, Michigan, USA.
  • Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Cardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
  • Clinic Cardiovascular Institute, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.

Zitieren

APA

Nuche, J., Abbas, A. E., Serra, V., Vilalta, V., Nombela-Franco, L., Regueiro, A., Al-Azizi, K. M., Iskander, A., Conradi, L., Forcillo, J., Lilly, S., Calabuig, A., Fernandez-Nofrerias, E., Mohammadi, S., Giuliani, C., Pelletier-Beaumont, E., Pibarot, P., & Rodés-Cabau, J. (2023). Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses. JACC: Cardiovascular Interventions, 16(24), 2999-3012. https://doi.org/10.1016/j.jcin.2023.10.028

Vancouver

Nuche J, Abbas AE, Serra V, Vilalta V, Nombela-Franco L, Regueiro A, et al. Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses. JACC: Cardiovascular Interventions. 2023;16(24):2999-3012. doi:10.1016/j.jcin.2023.10.028

BibTeX
@article{Nuche2023,
  author = {Nuche, Jorge and Abbas, Amr E and Serra, Vicenç and Vilalta, Victoria and Nombela-Franco, Luis and Regueiro, Ander and Al-Azizi, Karim M and Iskander, Ayman and Conradi, Lenard and Forcillo, Jessica and Lilly, Scott and Calabuig, Alvaro and Fernandez-Nofrerias, Eduard and Mohammadi, Siamak and Giuliani, Carlos and Pelletier-Beaumont, Emilie and Pibarot, Philippe and Rodés-Cabau, Josep},
  title = {Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses},
  journal = {JACC: Cardiovascular Interventions},
  year = {2023},
  volume = {16},
  number = {24},
  pages = {2999--3012},
  doi = {10.1016/j.jcin.2023.10.028}
}
Kostenlos starten →